Covered recipient · General Payments record
CHRISTINE FEATHERS
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2021–2024
$917.02
- Reported across 51 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $195.17 | 10 |
| Education | $99.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $99.99 | 1 |
| ABBVIE INC. | $60.67 | 3 |
| Novo Nordisk AS | $51.27 | 3 |
| Merck Sharp & Dohme Corporation | $28.57 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $20.41 | 1 |
| Lilly USA, LLC | $18.02 | 1 |
| DEXCOM, INC. | $16.23 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.28 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103716467 | CMS |
| ABBVIE INC. | $23.87 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103716469 | CMS |
| ABBVIE INC. | $14.52 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103716471 | CMS |
| Astellas Pharma US Inc | $99.99 | 01/17/2024 | Education | Undisputed | 01/23/2026 | 1139529260 | CMS |
| Dexcom, Inc. | $16.23 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153354704 | CMS |
| Lilly USA, LLC | $18.02 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135545535 | CMS |
| Merck Sharp & Dohme LLC | $28.57 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141677225 | CMS |
| Novartis Pharmaceuticals Corporation | $20.41 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086946695 | CMS |
| Novo Nordisk Inc | $18.54 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108565259 | CMS |
| Novo Nordisk Inc | $15.30 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108564601 | CMS |
| Novo Nordisk Inc | $17.43 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108570890 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.